Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

In vivo studies show efficacy for LY-379268 in opiate relapse

Sep. 15, 2005

Lateral hypothalamus orexin neurons: new targets for addiction

Sep. 12, 2005

Patient recruitment for phase I evaluation of N-acetylcysteine in cocaine dependence

Sep. 7, 2005

Memantine for cocaine and tobacco addiction

Sep. 7, 2005

GSK-3: an important target for opioid tolerance

Aug. 29, 2005

TA-CD shows efficacy in reducing drug use in cocaine-dependent subjects

Aug. 10, 2005

NicVAX European study completes enrollment

July 26, 2005

Priority review for Exjade in Canada

July 19, 2005

Buprenorphine attracts different patients with opioid dependence

July 13, 2005

Neumune cleared for U.S. human studies

July 7, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...